Onebright makes two senior appointments

Onebright, an outpatient mental healthcare company, has made two senior hires with the appointments of Tim Dunn as chief commercial officer and Dr Gabrielle Pendlebury as clinical director of psychiatric services.

Dunn will be in charge of all areas of the company’s commercial responsibilities, including sales, marketing, and product development, as well as ensuring that people who need it have access to high-quality treatment. He comes from Cigna, a healthcare and insurance organisation, and has previously worked at AXA.

Pendlebury is in charge of expanding existing psychiatric services and establishing new ones in order to fulfil the current global need for high-quality, evidence-based mental healthcare. With Pendlebury’s appointment, Onebright will establish bespoke routes that address the expanding need for assessment and treatment of mental health illnesses across the lifetime. Onebright presently has a national network of psychiatrists who provide remote and face-to-face consultations.

Pendlebury joins Onebright’s clinical governance board. Onebright’s extensive clinical governance structure is supported by an elite team of industry-leading clinicians and clinical consultants.

Pendlebury is a specialist child and adolescent psychiatrist with experience in forensic adolescent psychiatry and neurodevelopmental problems. She received her training at the Maudsley Hospital in London. She has worked as a Medicolegal Consultant, assisting and advising doctors in criminal, disciplinary, and regulatory concerns, as well as establishing services in both the NHS and the private sector.

Onebright CEO Donald Fowler says: “We are committed to quality of care and leading with integrity and compassion, delivering a recovery-focused service that gives people rapid access to high-quality mental healthcare when they need it. I am very pleased that Tim and Gabrielle have joined Onebright. Their knowledge and expertise will enable us to continue to deliver our high standards of clinical care and great clinical outcomes, as well as deliver our plans for growth and the launch of new service lines this year.” 

Exit mobile version